Exploring the retracted study on dihydroartemisinin and photodynamic therapy for esophageal cancer, examining the science behind targeting cancer metabolism.
Explore how IACS-10759 targets cancer's metabolic vulnerabilities through OXPHOS inhibition, offering new hope for treating aggressive cancers.
Explore the journey of IACS-010759, a mitochondrial complex I inhibitor that showed promise in targeting cancer metabolism but faced challenges in clinical trials.
Explore how cancer cells reprogram enzyme synthesis to fuel growth and survival, and discover promising therapeutic approaches targeting these molecular mechanisms.